News and Announcements
CRYPTO20 Fully Operational Weeks Ahead of Schedule; Token Sale Closing Soon!
- Published November 21, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- CRYPTO20 token sale closes on November 30th, 2017 (Noon GMT).
- CRPYTO20 have updated their website to allow for tracking of the fund value and composition in real-time.
- This is not your regular ICO.
We are excited to officially announce that CRYPTO20, the world’s’ first autonomous cryptocurrency index, has successfully completed the first rebalancing procedure weeks ahead of schedule. This includes a website update so that you can now track the fund value and composition in real-time.
This index is now fully operational and holds the top 20 cryptocurrency assets by market cap, weighted by the CRYPTO20 data-science optimized hyper-parameters detailed in the C20 website and whitepaper. Check out www.crypto20.com
Participation in this fund is through the acquisition of C20 tokens which can be acquired through the CRYPTO20 website until November 30th, 2017 (Noon GMT). Thereafter no more tokens will be sold. Tokens will be available on crypto-exchanges in January 2018 and may well trade above their Net Asset Value (NAV).
Any ICO contributions into CRYPTO20 from here on out will instantly diversify their single currency contribution a corresponding share of the top 20 cryptocurrencies.
The CRYPTO20 team are sincerely appreciative of the overwhelming amount of support from their growing global community – the 6,000+ contributors from all over the globe who are making this all possible. The dream of peace-of-mind cryptocurrency investment without intermediaries is going to be realized.
If you haven’t seen it yet, visit the Crypto20 Slack here and become part of the most genuine, helpful, informative and entertaining crypto community on the internet.
The clock is ticking… no more tokens after November 30th, 2017.
About CRYPTO20
CRYPTO20 is the first tokenized cryptocurrency index fund. Autonomous, powered by data science, in a proven fund structure and directly tied to the top 20 underlying crypto assets by the smart contract. Owning a diverse, rebalanced cryptocurrency portfolio is now as easy as holding a single token.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
